Cocrystal Pharma, Inc.

Common Stock SEC Reporting - Current
Verified Company Profile 10/10/2016
Contact Info
  • 1860 Montreal Road
  • Tucker, GA 30084

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0001412486
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o
Incorporated In: DE, USA
Year of Inc. 2006
Employees Not Available
Company Officers/Contacts
Gary Wilcox Interim CEO
Sam Lee President
Curtis S Dale CFO
Walt Addison Linscot General Counsel, Corporate Secretary
Company Directors
Raymond Schinazi Chairman
Gary Wilcox Chairman
David Block
Phillip Frost
Jane H. Hsiao
Steve Rubin
Company Notes
  • Domicile change from Nevada to Delaware
  • Formerly=Biozone Pharmaceuticals, Inc. until 4-2014
  • Formerly=International Surf Resorts, Inc. until 3-2011
Service Providers
Accounting/Auditing Firm
945 E Park Drive
Suite 103
Harrisburg, PA, 17111
United States

Legal Counsel
Nason, Yeager, Gerson, White & Lioce P.A.
3001 PGA Boulevard, Suite 305
Palm Beach Gardens, FL, 33410
United States

Investor Relations Firm
Not Available
COCP Security Details
Share Structure
Market Value1 $304,177,432 a/o Dec 09, 2016
Authorized Shares 800,000,000 a/o Nov 17, 2016
Outstanding Shares 714,031,530 a/o Nov 17, 2016
-Restricted 622,359,173 a/o Nov 17, 2016
-Unrestricted 91,672,357 a/o Nov 17, 2016
Held at DTC 90,804,697 a/o Nov 17, 2016
Float 86,561,000 a/o Apr 29, 2015
Par Value 0.001
Transfer Agent(s) Verified by Transfer Agent
Equity Stock Transfer
Shareholders of Record 234 a/o Sep 30, 2016
Short Selling Data
Short Interest 2,393,414 (3.17%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security